Cite
APA Citation
De Bono, J., Higano, C., Blumenstein, B., Feyerabend, S., Gravis, G., Ferrero, J., Jacobs, C., & Chi, K. (n.d.). 2560 Baseline serum clusterin level in patients with poor prognostic features was associated with response to custirsen treatment: Results from the phase 3 SYNERGY trial of docetaxel +/- custirsen. European journal of cancer, 51, S497–. http://access.bl.uk/ark:/81055/vdc_100030628240.0x000043